# 3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

> **NCT02446847** · PHASE2 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 16 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** 3BNC117
- **OTHER:** ART Interruption

## Key facts

- **NCT ID:** NCT02446847
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-11
- **Primary completion:** 2017-03-25
- **Final completion:** 2017-03-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446847, "3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02446847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*